BWM
ATRC icon

Baystate Wealth Management’s AtriCure ATRC Stock Holding History

Baystate Wealth Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-98
Closed -$4.84K – 1034
2023
Q2 		$4.84K Hold
98
– – ﹤0.01% 704
2023
Q1 		$4.06K Buy
+98
New +$4.07K ﹤0.01% 719

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baystate Wealth Management's ATRC Position: Q3 2023 in Review

Baystate Wealth Management sold out of AtriCure (ATRC) in Q3 2023, closing a stake of 98 shares — an estimated $4.84K sold.

Baystate Wealth Management first reported a position in ATRC in Q1 2023 and held it in 2 quarters. The position peaked at $4.84K in Q2 2023. 230 funds tracked by Wall St. Rank hold ATRC as of Q3 2023.

  • Baystate Wealth Management reported no remaining AtriCure position as of Q3 2023 after selling out during the quarter.
  • Baystate Wealth Management sold 98 AtriCure shares in Q3 2023, an estimated $4.84K.
  • Baystate Wealth Management first reported a position in AtriCure in Q1 2023 and held it in 2 quarters.
  • Baystate Wealth Management's AtriCure position peaked at $4.84K in Q2 2023.
  • 230 funds tracked by Wall St. Rank held AtriCure as of Q3 2023.

Based on Baystate Wealth Management's 13F filing for Q3 2023, filed 26 Oct 2023.